Rethinking eGFR Comparisons in SGLT2 Inhibitor Research
- PMID: 38418012
- DOI: 10.1016/j.jacc.2023.09.838
Rethinking eGFR Comparisons in SGLT2 Inhibitor Research
Comment in
-
Reply: Rethinking eGFR Comparisons in SGLT2 Inhibitor Research.J Am Coll Cardiol. 2024 Mar 5;83(9):e89. doi: 10.1016/j.jacc.2023.12.030. J Am Coll Cardiol. 2024. PMID: 38418013 No abstract available.
Comment on
-
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function.J Am Coll Cardiol. 2023 Nov 7;82(19):1854-1863. doi: 10.1016/j.jacc.2023.08.026. Epub 2023 Aug 25. J Am Coll Cardiol. 2023. PMID: 37634707
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous